HighTower Advisors’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,114
| Closed | -$348K | – | 3860 |
|
|
2023
Q4 | $348K | Buy |
+5,114
| New | +$356K | ﹤0.01% | 2598 |
|
|
2023
Q3 | – | Sell |
-2,627
| Closed | -$241K | – | 3682 |
|
|
2023
Q2 | $241K | Sell |
2,627
-29
| -1% | -$2.58K | ﹤0.01% | 2724 |
|
|
2023
Q1 | $275K | Sell |
2,656
-167
| -6% | -$18.5K | ﹤0.01% | 2526 |
|
|
2022
Q4 | $326K | Sell |
2,823
-489
| -15% | -$56.9K | ﹤0.01% | 2412 |
|
|
2022
Q3 | $353K | Buy |
3,312
+638
| +24% | +$91.4K | ﹤0.01% | 2240 |
|
|
2022
Q2 | $483K | Buy |
2,674
+74
| +3% | +$13.2K | ﹤0.01% | 2078 |
|
|
2022
Q1 | $443K | Buy |
2,600
+86
| +3% | +$16.2K | ﹤0.01% | 2260 |
|
|
2021
Q4 | $525K | Sell |
2,514
-67
| -3% | -$13.8K | ﹤0.01% | 2122 |
|
|
2021
Q3 | $498K | Buy |
2,581
+277
| +12% | +$68.1K | ﹤0.01% | 2056 |
|
|
2021
Q2 | $652K | Sell |
2,304
-34
| -1% | -$9.21K | ﹤0.01% | 1901 |
|
|
2021
Q1 | $495K | Sell |
2,338
-20
| -0.8% | -$4.79K | ﹤0.01% | 1979 |
|
|
2020
Q4 | $463K | Sell |
2,358
-100
| -4% | -$17.7K | ﹤0.01% | 1678 |
|
|
2020
Q3 | $403K | Buy |
2,458
+14
| +0.6% | +$2.31K | ﹤0.01% | 1673 |
|
|
2020
Q2 | $340K | Buy |
+2,444
| New | +$224K | ﹤0.01% | 1660 |
|
|
2020
Q1 | – | Sell |
-2,298
| Closed | -$252K | – | 2396 |
|
|
2019
Q4 | $252K | Sell |
2,298
-128
| -5% | -$12.4K | ﹤0.01% | 1823 |
|
|
2019
Q3 | $252K | Buy |
2,426
+87
| +4% | +$9.35K | ﹤0.01% | 1916 |
|
|
2019
Q2 | $299K | Buy |
2,339
+99
| +4% | +$13.8K | ﹤0.01% | 1805 |
|
|
2019
Q1 | $285K | Buy |
2,240
+54
| +2% | +$6.85K | ﹤0.01% | 1735 |
|
|
2018
Q4 | $274K | Buy |
2,186
+93
| +4% | +$15.9K | ﹤0.01% | 1659 |
|
|
2018
Q3 | $462K | Buy |
2,093
+260
| +14% | +$52.7K | ﹤0.01% | 1492 |
|
|
2018
Q2 | $293K | Buy |
+1,833
| New | +$234K | ﹤0.01% | 1700 |
|
|
2018
Q1 | – | Sell |
-7,096
| Closed | -$495K | – | 2278 |
|
|
2017
Q4 | $495K | Buy |
7,096
+1,761
| +33% | +$117K | ﹤0.01% | 1453 |
|
|
2017
Q3 | $317K | Buy |
+5,335
| New | +$265K | ﹤0.01% | 1661 |
|
|
2016
Q4 | – | Sell |
-5,921
| Closed | -$225K | – | 1992 |
|
|
2016
Q3 | $225K | Sell |
5,921
-218
| -4% | -$7.82K | ﹤0.01% | 1586 |
|
|
2016
Q2 | $204K | Buy |
+6,139
| New | +$198K | ﹤0.01% | 1489 |
|
Other funds holding MED
HighTower Advisors's MED Position: Q1 2024 in Review
HighTower Advisors sold out of Medifast (MED) in Q1 2024, closing a stake of 5,114 shares — an estimated $348K sold.
HighTower Advisors first reported a position in MED in Q2 2016 and held it in 25 quarters. The position peaked at $652K in Q2 2021. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.
- HighTower Advisors reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
- HighTower Advisors sold 5,114 Medifast shares in Q1 2024, an estimated $348K.
- HighTower Advisors first reported a position in Medifast in Q2 2016 and held it in 25 quarters.
- HighTower Advisors's Medifast position peaked at $652K in Q2 2021.
- 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.
Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.